GNRRF
GeNeuro SA

0
Mkt Cap
$1.18M
Volume
60.00
52W High
$4.55
52W Low
$4.55
PE Ratio
-10.13
GNRRF Fundamentals
Price
$4.55
Prev Close
$4.55
Open
$4.55
50D MA
$4.55
Beta
0.00
Avg. Volume
0.00
P/B
14.29
Loading...
Loading...
GeNeuro SA engages in the research and development of treatments against neurological disorders and autoimmune disease. The firm's lead therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic human endogenous retroviruses (HERV) protein of the W family called pHERV-W env that has been identified as a factor in the onset and development of autoimmune diseases. The company was founded by Herve Perron and Jesus Martin-Garcia in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of GeNeuro SA?
What is the 52-week high for GeNeuro SA?
What is the 52-week low for GeNeuro SA?
What is GeNeuro SA stock price today?
What was GeNeuro SA stock price yesterday?
What is the PE ratio of GeNeuro SA?
What is the Price-to-Book ratio of GeNeuro SA?
What is the 50-day moving average of GeNeuro SA?

Latest GNRRF News

View
No GNRRF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.